Global and United States Circulating Biomarker for Liquid Biopsy Market Report & Forecast 2022-2028

Publisher Name :
Date: 25-May-2022
No. of pages: 85
Inquire Before Buying

Circulating Biomarker for Liquid Biopsy market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Circulating Biomarker for Liquid Biopsy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Circulating Biomarker for Liquid Biopsy market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type

- Circulating Tumor Cells (CTCs)

- Circulating Tumor DNA (ctDNA)

- Cell-Free DNA (cfDNA)

- Extracellular Vesicles (EVs)

- Others

Segment by Application

- Early Cancer Screening

- Therapy Selection

- Treatment Monitoring

- Recurrence Monitoring Orthopedics

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

By Company

- Abbott Laboratories

- Becton, Dickinson and Company

- GE Healthcare

- Epigenomics AG

- Agilent Technologies

- Biocept

- Affymetrix

- Fluxion Biosciences

Global and United States Circulating Biomarker for Liquid Biopsy Market Report & Forecast 2022-2028

Table of Contents
1 Study Coverage
1.1 Circulating Biomarker for Liquid Biopsy Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022) & (US$ Million) Introduction
1.2 Global Circulating Biomarker for Liquid Biopsy Outlook 2017 VS 2022 VS 2028
1.2.1 Global Circulating Biomarker for Liquid Biopsy Market Size for the Year 2017-2028
1.2.2 Global Circulating Biomarker for Liquid Biopsy Market Size for the Year 2017-2028
1.3 Circulating Biomarker for Liquid Biopsy Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Circulating Biomarker for Liquid Biopsy in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Circulating Biomarker for Liquid Biopsy Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Circulating Biomarker for Liquid Biopsy Market Dynamics
1.4.1 Circulating Biomarker for Liquid Biopsy Industry Trends
1.4.2 Circulating Biomarker for Liquid Biopsy Market Drivers
1.4.3 Circulating Biomarker for Liquid Biopsy Market Challenges
1.4.4 Circulating Biomarker for Liquid Biopsy Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Circulating Biomarker for Liquid Biopsy by Type
2.1 Circulating Biomarker for Liquid Biopsy Market Segment by Type
2.1.1 Circulating Tumor Cells (CTCs)
2.1.2 Circulating Tumor DNA (ctDNA)
2.1.3 Cell-Free DNA (cfDNA)
2.1.4 Extracellular Vesicles (EVs)
2.1.5 Others
2.2 Global Circulating Biomarker for Liquid Biopsy Market Size by Type (2017, 2022 & 2028)
2.3 Global Circulating Biomarker for Liquid Biopsy Market Size by Type (2017-2028)
2.4 United States Circulating Biomarker for Liquid Biopsy Market Size by Type (2017, 2022 & 2028)
2.5 United States Circulating Biomarker for Liquid Biopsy Market Size by Type (2017-2028)
3 Circulating Biomarker for Liquid Biopsy by Application
3.1 Circulating Biomarker for Liquid Biopsy Market Segment by Application
3.1.1 Early Cancer Screening
3.1.2 Therapy Selection
3.1.3 Treatment Monitoring
3.1.4 Recurrence Monitoring Orthopedics
3.2 Global Circulating Biomarker for Liquid Biopsy Market Size by Application (2017, 2022 & 2028)
3.3 Global Circulating Biomarker for Liquid Biopsy Market Size by Application (2017-2028)
3.4 United States Circulating Biomarker for Liquid Biopsy Market Size by Application (2017, 2022 & 2028)
3.5 United States Circulating Biomarker for Liquid Biopsy Market Size by Application (2017-2028)
4 Global Circulating Biomarker for Liquid Biopsy Competitor Landscape by Company
4.1 Global Circulating Biomarker for Liquid Biopsy Market Size by Company
4.1.1 Top Global Circulating Biomarker for Liquid Biopsy Companies Ranked by Revenue (2021)
4.1.2 Global Circulating Biomarker for Liquid Biopsy Revenue by Player (2017-2022)
4.2 Global Circulating Biomarker for Liquid Biopsy Concentration Ratio (CR)
4.2.1 Circulating Biomarker for Liquid Biopsy Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Circulating Biomarker for Liquid Biopsy in 2021
4.2.3 Global Circulating Biomarker for Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Circulating Biomarker for Liquid Biopsy Headquarters, Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022) & (US$ Million) Type
4.3.1 Global Circulating Biomarker for Liquid Biopsy Headquarters and Area Served
4.3.2 Global Circulating Biomarker for Liquid Biopsy Companies Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Circulating Biomarker for Liquid Biopsy Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Circulating Biomarker for Liquid Biopsy Market Size by Company
4.5.1 Top Circulating Biomarker for Liquid Biopsy Players in United States, Ranked by Revenue (2021)
4.5.2 United States Circulating Biomarker for Liquid Biopsy Revenue by Players (2020, 2021 & 2022)
5 Global Circulating Biomarker for Liquid Biopsy Market Size by Region
5.1 Global Circulating Biomarker for Liquid Biopsy Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Circulating Biomarker for Liquid Biopsy Market Size by Region (2017-2028)
5.2.1 Global Circulating Biomarker for Liquid Biopsy Market Size by Region: 2017-2022
5.2.2 Global Circulating Biomarker for Liquid Biopsy Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Circulating Biomarker for Liquid Biopsy Market Size YoY Growth 2017-2028
6.1.2 North America Circulating Biomarker for Liquid Biopsy Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Circulating Biomarker for Liquid Biopsy Market Size YoY Growth 2017-2028
6.3.2 Europe Circulating Biomarker for Liquid Biopsy Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Circulating Biomarker for Liquid Biopsy Market Size YoY Growth 2017-2028
6.4.2 Latin America Circulating Biomarker for Liquid Biopsy Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Circulating Biomarker for Liquid Biopsy Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Circulating Biomarker for Liquid Biopsy Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Company Details
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Circulating Biomarker for Liquid Biopsy Introduction
7.1.4 Abbott Laboratories Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
7.1.5 Abbott Laboratories Recent Development
7.2 Becton, Dickinson and Company
7.2.1 Becton, Dickinson and Company Company Details
7.2.2 Becton, Dickinson and Company Business Overview
7.2.3 Becton, Dickinson and Company Circulating Biomarker for Liquid Biopsy Introduction
7.2.4 Becton, Dickinson and Company Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
7.2.5 Becton, Dickinson and Company Recent Development
7.3 GE Healthcare
7.3.1 GE Healthcare Company Details
7.3.2 GE Healthcare Business Overview
7.3.3 GE Healthcare Circulating Biomarker for Liquid Biopsy Introduction
7.3.4 GE Healthcare Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
7.3.5 GE Healthcare Recent Development
7.4 Epigenomics AG
7.4.1 Epigenomics AG Company Details
7.4.2 Epigenomics AG Business Overview
7.4.3 Epigenomics AG Circulating Biomarker for Liquid Biopsy Introduction
7.4.4 Epigenomics AG Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
7.4.5 Epigenomics AG Recent Development
7.5 Agilent Technologies
7.5.1 Agilent Technologies Company Details
7.5.2 Agilent Technologies Business Overview
7.5.3 Agilent Technologies Circulating Biomarker for Liquid Biopsy Introduction
7.5.4 Agilent Technologies Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
7.5.5 Agilent Technologies Recent Development
7.6 Biocept
7.6.1 Biocept Company Details
7.6.2 Biocept Business Overview
7.6.3 Biocept Circulating Biomarker for Liquid Biopsy Introduction
7.6.4 Biocept Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
7.6.5 Biocept Recent Development
7.7 Affymetrix
7.7.1 Affymetrix Company Details
7.7.2 Affymetrix Business Overview
7.7.3 Affymetrix Circulating Biomarker for Liquid Biopsy Introduction
7.7.4 Affymetrix Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
7.7.5 Affymetrix Recent Development
7.8 Fluxion Biosciences
7.8.1 Fluxion Biosciences Company Details
7.8.2 Fluxion Biosciences Business Overview
7.8.3 Fluxion Biosciences Circulating Biomarker for Liquid Biopsy Introduction
7.8.4 Fluxion Biosciences Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
7.8.5 Fluxion Biosciences Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Tables
Table 1. Circulating Biomarker for Liquid Biopsy Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Circulating Biomarker for Liquid Biopsy Market Trends
Table 3. Circulating Biomarker for Liquid Biopsy Market Drivers
Table 4. Circulating Biomarker for Liquid Biopsy Market Challenges
Table 5. Circulating Biomarker for Liquid Biopsy Market Restraints
Table 6. Global Circulating Biomarker for Liquid Biopsy Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Circulating Biomarker for Liquid Biopsy Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Circulating Biomarker for Liquid Biopsy Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Circulating Biomarker for Liquid Biopsy Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Circulating Biomarker for Liquid Biopsy Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Circulating Biomarker for Liquid Biopsy Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Circulating Biomarker for Liquid Biopsy Revenue Share by Player, 2017-2022
Table 13. Global Circulating Biomarker for Liquid Biopsy Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Circulating Biomarker for Liquid Biopsy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Biomarker for Liquid Biopsy as of 2021)
Table 15. Top Players of Circulating Biomarker for Liquid Biopsy in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Circulating Biomarker for Liquid Biopsy Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Circulating Biomarker for Liquid Biopsy Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Circulating Biomarker for Liquid Biopsy Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Circulating Biomarker for Liquid Biopsy Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Circulating Biomarker for Liquid Biopsy Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Circulating Biomarker for Liquid Biopsy Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Circulating Biomarker for Liquid Biopsy Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Circulating Biomarker for Liquid Biopsy Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Circulating Biomarker for Liquid Biopsy Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Circulating Biomarker for Liquid Biopsy Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Circulating Biomarker for Liquid Biopsy Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Circulating Biomarker for Liquid Biopsy Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Abbott Laboratories Company Details
Table 31. Abbott Laboratories Business Overview
Table 32. Abbott Laboratories Circulating Biomarker for Liquid Biopsy Product
Table 33. Abbott Laboratories Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022) & (US$ Million)
Table 34. Abbott Laboratories Recent Development
Table 35. Becton, Dickinson and Company Company Details
Table 36. Becton, Dickinson and Company Business Overview
Table 37. Becton, Dickinson and Company Circulating Biomarker for Liquid Biopsy Product
Table 38. Becton, Dickinson and Company Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022) & (US$ Million)
Table 39. Becton, Dickinson and Company Recent Development
Table 40. GE Healthcare Company Details
Table 41. GE Healthcare Business Overview
Table 42. GE Healthcare Circulating Biomarker for Liquid Biopsy Product
Table 43. GE Healthcare Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022) & (US$ Million)
Table 44. GE Healthcare Recent Development
Table 45. Epigenomics AG Company Details
Table 46. Epigenomics AG Business Overview
Table 47. Epigenomics AG Circulating Biomarker for Liquid Biopsy Product
Table 48. Epigenomics AG Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022) & (US$ Million)
Table 49. Epigenomics AG Recent Development
Table 50. Agilent Technologies Company Details
Table 51. Agilent Technologies Business Overview
Table 52. Agilent Technologies Circulating Biomarker for Liquid Biopsy Product
Table 53. Agilent Technologies Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022) & (US$ Million)
Table 54. Agilent Technologies Recent Development
Table 55. Biocept Company Details
Table 56. Biocept Business Overview
Table 57. Biocept Circulating Biomarker for Liquid Biopsy Product
Table 58. Biocept Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022) & (US$ Million)
Table 59. Biocept Recent Development
Table 60. Affymetrix Company Details
Table 61. Affymetrix Business Overview
Table 62. Affymetrix Circulating Biomarker for Liquid Biopsy Product
Table 63. Affymetrix Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022) & (US$ Million)
Table 64. Affymetrix Recent Development
Table 65. Fluxion Biosciences Company Details
Table 66. Fluxion Biosciences Business Overview
Table 67. Fluxion Biosciences Circulating Biomarker for Liquid Biopsy Product
Table 68. Fluxion Biosciences Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022) & (US$ Million)
Table 69. Fluxion Biosciences Recent Development
Table 70. Research Programs/Design for This Report
Table 71. Key Data Information from Secondary Sources
Table 72. Key Data Information from Primary Sources
List of Figures
Figure 1. Circulating Biomarker for Liquid Biopsy Product Picture
Figure 2. Global Circulating Biomarker for Liquid Biopsy Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Circulating Biomarker for Liquid Biopsy Market Size 2017-2028 (US$ Million)
Figure 4. United States Circulating Biomarker for Liquid Biopsy Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Circulating Biomarker for Liquid Biopsy Market Size 2017-2028 (US$ Million)
Figure 6. United States Circulating Biomarker for Liquid Biopsy Market Share in Global 2017-2028
Figure 7. Circulating Biomarker for Liquid Biopsy Report Years Considered
Figure 8. Product Picture of Circulating Tumor Cells (CTCs)
Figure 9. Product Picture of Circulating Tumor DNA (ctDNA)
Figure 10. Product Picture of Cell-Free DNA (cfDNA)
Figure 11. Product Picture of Extracellular Vesicles (EVs)
Figure 12. Product Picture of Others
Figure 13. Global Circulating Biomarker for Liquid Biopsy Market Share by Type in 2022 & 2028
Figure 14. Global Circulating Biomarker for Liquid Biopsy Market Size by Type (2017-2028) & (US$ Million)
Figure 15. Global Circulating Biomarker for Liquid Biopsy Market Share by Type (2017-2028)
Figure 16. United States Circulating Biomarker for Liquid Biopsy Market Share by Type in 2022 & 2028
Figure 17. United States Circulating Biomarker for Liquid Biopsy Market Size by Type (2017-2028) & (US$ Million)
Figure 18. United States Circulating Biomarker for Liquid Biopsy Market Share by Type (2017-2028)
Figure 19. Product Picture of Early Cancer Screening
Figure 20. Product Picture of Therapy Selection
Figure 21. Product Picture of Treatment Monitoring
Figure 22. Product Picture of Recurrence Monitoring Orthopedics
Figure 23. Global Circulating Biomarker for Liquid Biopsy Market Share by Application in 2022 & 2028
Figure 24. Global Circulating Biomarker for Liquid Biopsy Market Size by Application (2017-2028) & (US$ Million)
Figure 25. Global Circulating Biomarker for Liquid Biopsy Market Share by Application (2017-2028)
Figure 26. United States Circulating Biomarker for Liquid Biopsy Market Share by Application in 2022 & 2028
Figure 27. United States Circulating Biomarker for Liquid Biopsy Market Size by Application (2017-2028) & (US$ Million)
Figure 28. United States Circulating Biomarker for Liquid Biopsy Market Share by Application (2017-2028)
Figure 29. North America Circulating Biomarker for Liquid Biopsy Market Size Growth Rate 2017-2028 (US$ Million)
Figure 30. U.S. Circulating Biomarker for Liquid Biopsy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 31. Canada Circulating Biomarker for Liquid Biopsy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 32. Europe Circulating Biomarker for Liquid Biopsy Market Size Growth Rate 2017-2028 (US$ Million)
Figure 33. Germany Circulating Biomarker for Liquid Biopsy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. France Circulating Biomarker for Liquid Biopsy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 35. U.K. Circulating Biomarker for Liquid Biopsy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. Italy Circulating Biomarker for Liquid Biopsy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. Russia Circulating Biomarker for Liquid Biopsy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size Growth Rate 2017-2028 (US$ Million)
Figure 39. China Circulating Biomarker for Liquid Biopsy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. Japan Circulating Biomarker for Liquid Biopsy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. South Korea Circulating Biomarker for Liquid Biopsy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. India Circulating Biomarker for Liquid Biopsy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Australia Circulating Biomarker for Liquid Biopsy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Taiwan Circulating Biomarker for Liquid Biopsy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Indonesia Circulating Biomarker for Liquid Biopsy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 46. Thailand Circulating Biomarker for Liquid Biopsy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Malaysia Circulating Biomarker for Liquid Biopsy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Philippines Circulating Biomarker for Liquid Biopsy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 49. Latin America Circulating Biomarker for Liquid Biopsy Market Size Growth Rate 2017-2028 (US$ Million)
Figure 50. Mexico Circulating Biomarker for Liquid Biopsy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. Brazil Circulating Biomarker for Liquid Biopsy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. Argentina Circulating Biomarker for Liquid Biopsy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 53. Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size Growth Rate 2017-2028 (US$ Million)
Figure 54. Turkey Circulating Biomarker for Liquid Biopsy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia Circulating Biomarker for Liquid Biopsy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 56. UAE Circulating Biomarker for Liquid Biopsy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 57. Abbott Laboratories Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
Figure 58. Becton, Dickinson and Company Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
Figure 59. GE Healthcare Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
Figure 60. Epigenomics AG Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
Figure 61. Agilent Technologies Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
Figure 62. Biocept Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
Figure 63. Affymetrix Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
Figure 64. Fluxion Biosciences Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs